It has been dwindled way down to even a lesser number of drugs and may not make it through to the end legislation according to the last update.
POLITICO: 10/22/2021 - Dems eye slimmed-down drug price deal to advance social spending bill
from the link ~
Congressional Democrats are watering down — and may entirely drop — a plan to have the government directly negotiate some Medicare drug prices in order to help clinch a deal on their sweeping social spending package.
. . . . Negotiations among the House, Senate and White House on drug pricing in particular have intensified in recent days, in a bid to win over key holdouts and allies of the drug industry, including Sens. Bob Menendez (D-N.J.) and Tom Carper (D-Del.), along with Reps. Kurt Schrader (D-Ore.), Scott Peters (D-Calif.) and Kathleen Rice (D-N.Y.)
Though the situation remains fluid, Democrats say it’s likely the final bill will involve very limited government negotiation of drug prices, and there remains the possibility it could drop out entirely.
Senior Democrats familiar with the talks also said a key pillar of the plan — an excise tax on pharmaceutical companies that don't submit to negotiations — is off the table for now, in what could be a significant victory for the industry.
Guess we will have to continue to wait to see WHAT, IF ANYTHING gets passed and which (few) drugs may reach the "negotiated" finish line.
It's Always Something . . . . Roseanna Roseannadanna